Cantargia AB
STO:CANTA

Watchlist Manager
Cantargia AB Logo
Cantargia AB
STO:CANTA
Watchlist
Price: 1.812 SEK -2.42% Market Closed
Market Cap: 332.8m SEK
Have any thoughts about
Cantargia AB?
Write Note

Cantargia AB
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cantargia AB
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Cantargia AB
STO:CANTA
Selling, General & Administrative
-kr14.3m
CAGR 3-Years
3%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Selling, General & Administrative
-kr398.7m
CAGR 3-Years
-27%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Selling, General & Administrative
-kr575m
CAGR 3-Years
-39%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Selling, General & Administrative
-kr991m
CAGR 3-Years
-41%
CAGR 5-Years
-24%
CAGR 10-Years
-19%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Selling, General & Administrative
-kr7.2B
CAGR 3-Years
-20%
CAGR 5-Years
-19%
CAGR 10-Years
-26%
BioArctic AB
STO:BIOA B
Selling, General & Administrative
-kr200.3m
CAGR 3-Years
-47%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
No Stocks Found

Cantargia AB
Glance View

Market Cap
332.8m SEK
Industry
Biotechnology

Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. The company is headquartered in Lund, Skane. The company went IPO on 2015-03-17. The firm is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

CANTA Intrinsic Value
1.024 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cantargia AB's Selling, General & Administrative?
Selling, General & Administrative
-14.3m SEK

Based on the financial report for Sep 30, 2024, Cantargia AB's Selling, General & Administrative amounts to -14.3m SEK.

What is Cantargia AB's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-8%

Over the last year, the Selling, General & Administrative growth was 1%. The average annual Selling, General & Administrative growth rates for Cantargia AB have been 3% over the past three years , -8% over the past five years .

Back to Top